Advances in the Development of New Drugs and Treatment Targets for Brain Cancers
Materialtyp:
ArtikelUtgivningsinformation: MDPI - Multidisciplinary Digital Publishing Institute 2024Beskrivning: 1 electronic resource (176 p.)Innehållstyp: - text
- computer
- online resource
- 9783725814039
- 9783725814046
- Medicine
- Clinical & internal medicine
- Diseases and disorders
- Oncology
- HRMAS
- STAT3
- actin alpha
- actin alpha 2
- albendazole
- albendazole sulfoxide
- anastrozole
- astrocytoma
- brain tumors
- cardiac muscle 1 (ACTC1)
- cell migration
- cell-based therapy
- chalcones
- childhood cancers
- cytoskeleton
- diet
- ependymoma
- glioblastoma
- glucose
- high-grade glioma
- immune therapies
- inflammatory cytokines
- ketones
- liposomes
- locomotion
- low-grade gliomas
- macrophages
- magnetic resonance imaging
- magnetic resonance spectroscopy
- melatonin
- metabolism
- miRNA-125b
- molecular pathways
- monocytes
- nanoparticles
- nanotechnology
- neuropathology and classification
- oligodendroglioma
- outcome
- pediatric low-grade gliomas
- pediatrics
- polymersomes
- preclinical models
- radiation therapy
- rare low-grade gliomas
- recurrence
- rutin
- smooth muscle (ACTA2)
- surgery
- synergism
- synthesis
- targeted therapies
- targeted therapy
- treatment strategies
- tumor microenvironment
Open Access Unrestricted online access star
The Special Issue features original research articles and review articles that discuss new therapy tactics and target medications, emphasizing the significance of brain tumors at the cellular and molecular levels. In recent decades, potent chemotherapeutic agents, oligonucleotides, and antibodies for targeted therapy, multifunctional nanomedicines, immunotherapies, and cell-based therapies have been developed and proposed to overcome most of the issues that arise due to the locations of brain tumors and their biological barriers. Ongoing research is focused on comprehending the biology of brain tumors, discovering new treatment targets, and creating breakthrough medicines like immunotherapy and tailored drug delivery systems. These endeavors show potential for enhancing results and increasing survival rates in the future.
Creative Commons Licence cc by-nc-nd cc https://creativecommons.org/licenses/by-nc-nd/4.0/
eng
Freely available e-book